Weekly CEO News from Richard Ingram
October 30, 2015

Back on June 4th, I suggested that the bloom would soon be off the Elon “the next Steve Jobs” Musk, and that would express itself in the diminishment of price for SCTY and TSLA. As I put it, “One would

Read more

Credit Suisse has stumbled in its initial restructuring effort. Forced by Swiss regulators to deleverage more quickly, the bank has turned to several unenthusiastic steps in order to comply. The Swiss banking unit will see a partial public flotation not

Read more

  Calendar Trend Indicates Bullish 4 Month SPX Time Period Upcoming The old market axiom says ‘Sell in May and go away’ — meaning avoid the volatile summer months and return to larger allocations in November. With the end of October (and Halloween)

Read more

The last time S&P 500 rallied at such a pace (from an extreme of oversoldness) and reached such an extreme level of overboughtness, things went south rather quickly…   Charts: Bloomberg

Personal Income, Consumer Spending Weaker Than Economists Expect Today’s Personal Income and Outlays report came in below Consensus Estimates. Inflation is not building based on the Fed’s favorite reading, the core PCE price index which inched a lower-than-expected 0.1 percent higher

Read more

I have turned comments on for this post so that anyone with the answer (or an opinion) can chime in. I have not allowed comments for years now because a) I don’t have time for trolls and b) there was

Read more

Over the past week all of my core measures of market health rose with the exception of the economy, which held steady. As price for the S&P 500 Index (SPX) rises, the internal indicators continue to improve. There are some

Read more

US Session Bullet Report Gold is testing the 50 day moving average after dropping to another session low at $1140. Overall some short covering on the last day of the month is also responsible for the USD weakness. Apparent weakness

Read more

We will see how the overall pharma and biotech sectors hold up today on news that hit after the bell around recent sector pariah Valeant Pharmaceuticals (NYSE:VRX). Optum, the health services platform of UnitedHealth (NYSE:UNH), as well as CVS Health (NYSE:CVS)and Express Scripts (NASDAQ:ESRX) announced

Read more

Imaginary Numbers Yesterday we came across a Reuters report on the rather pedestrian, to put it mildly, third quarter GDP report. Reported “real” GDP was greatly helped by the GDP deflator once again declining sharply, coming in a full percentage point lower than

Read more